Type I surface antigen associated with staphylococcus epidermidis
AssigneeNabi
InventorsAli Ibrahim Fattom, Walter W. Karakawa, deceased, D. Craig Wright
Life of this patent
Estimating the term…
Loading patent…
AssigneeNabi
InventorsAli Ibrahim Fattom, Walter W. Karakawa, deceased, D. Craig Wright
Estimating the term…
A process is disclosed for culturing clinical Staphylococcus epidermidis cells that reproducibly enables identification of a limited number of predominant serotypes. Two predominant serotypes common to most clinical cases of S. epidermidis have been identified and are denoted Type I and Type II. A particular polysaccharide surface antigen is associated with each of the Type I and Type II serotypes. The surface antigens can be used to provide active and passive immunization against S. epidermidis infection and to produce a hyperimmune immunoglobulin or antibodies for treatment of S. epidermidis infection.
A vaccine comprising a sterile, pharmaceutically-acceptable carrier and a composition consisting essentially of a polysaccharide antigen that is obtained by a process comprising steps of:
Dependencies are inferred from the claim text.